What The Study Did: Researchers examined whether Medicaid patients in Wisconsin with opioid use disorder experienced decreased access to treatment, including receiving buprenorphine and urine drug testing during the COVID-19 pandemic.
Authors: Alyssa Shell Tilhou, M.D., Ph.D., of the Boston University School of Medicine/Boston Medical Center, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.0093?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031122
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
JAMA Health Forum